Maxime Dougados

68.3k total citations · 10 hit papers
546 papers, 23.9k citations indexed

About

Maxime Dougados is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Maxime Dougados has authored 546 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 478 papers in Rheumatology, 210 papers in Immunology and 114 papers in Hematology. Recurrent topics in Maxime Dougados's work include Rheumatoid Arthritis Research and Therapies (356 papers), Spondyloarthritis Studies and Treatments (335 papers) and Psoriasis: Treatment and Pathogenesis (169 papers). Maxime Dougados is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (356 papers), Spondyloarthritis Studies and Treatments (335 papers) and Psoriasis: Treatment and Pathogenesis (169 papers). Maxime Dougados collaborates with scholars based in France, Netherlands and United States. Maxime Dougados's co-authors include Désirée van der Heijde, Joachim Sieper, Robert Landewé, Jürgen Braun, Laure Gossec, Sofía Ramiro, Paul Emery, Walter P. Maksymowych, B Amor and Andrei Călin and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Maxime Dougados

515 papers receiving 23.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy

1991 1.7k citations Maxime Dougados et al. profile →
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

2009 1.2k citations Joachim Sieper, Xenofon Baraliakos et al. Annals of the Rheumatic Diseases profile →
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

2015 732 citations Dominique Baeten, Joachim Sieper et al. profile →
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

2006 660 citations Désirée van der Heijde, Alan Kivitz et al. profile →
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

2008 624 citations Maxime Dougados et al. Annals of the Rheumatic Diseases profile →
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

2003 583 citations Désirée van der Heijde, Jürgen Braun et al. profile →
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

2004 512 citations Maxime Dougados, Paul Emery et al. Annals of the Rheumatic Diseases profile →
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

2016 301 citations Maxime Dougados, Désirée van der Heijde et al. Annals of the Rheumatic Diseases profile →
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis

2020 195 citations Alexandre Sepriano, Désirée van der Heijde et al. Annals of the Rheumatic Diseases profile →
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

2022 123 citations Maxime Dougados, Zoltán Szekanecz et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Maxime Dougados

Since Specialization

Citations

This map shows the geographic impact of Maxime Dougados's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Dougados with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Dougados more than expected).

Fields of papers citing papers by Maxime Dougados

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Dougados. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Dougados. The network helps show where Maxime Dougados may publish in the future.

Co-authorship network of co-authors of Maxime Dougados

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Dougados. A scholar is included among the top collaborators of Maxime Dougados based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Dougados. Maxime Dougados is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of instruments assessing peripheral arthritis in spondyloarthritis: an analysis of the ASAS-PerSpA study 2025 ·Annals of the Rheumatic Diseases ·(unknown), Clementina López‐Medina, Désirée van der Heijde, Robert Landewé, Maxime Dougados, Joachim Sieper, Anna Moltó, Sofía Ramiro	2
2	Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort 2024 ·Annals of the Rheumatic Diseases ·Anna Moltó, Clementina López‐Medina, Alexandre Sepriano, Sofía Ramiro, Manouk de Hooge, M. van Lunteren, Victoria Navarro‐Compán, Daniel Wendling, Maxime Dougados	10
3	Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial 2024 ·Seminars in Arthritis and Rheumatism ·Uta Kiltz, Anna Moltó, Clementina López‐Medina, Maxime Dougados, Désirée van der Heijde, Annelies Boonen, Filip Van den Bosch, Jürgen Braun	0
4	Different disease activity trajectories in early axial spondyloarthritis lead to significantly different long-term outcomes: a trajectory-based analysis of the DESIR cohort over 10 years 2024 ·RMD Open ·(unknown), (unknown), Matthieu Resche‐Rigon, Maxime Dougados, Laure Gossec, Anna Moltó	1
5	Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from the international ASAS-COMOSPA study 2024 ·Lara D. Veeken ·(unknown), Clementina López‐Medina, (unknown), (unknown), José A. Maldonado‐Cocco, Anna Moltó, Maxime Dougados, Robert Landewé, Désirée van der Heijde, Filip Van den Bosch	2
6	Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data 2023 ·Arthritis Research & Therapy ·(unknown), Lourdes Ladehesa-Pineda, (unknown), Alejandro Escudero‐Contreras, Maxime Dougados, Eduardo Collantes‐Estévez, Clementina López‐Medina	3
7	Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritis 2023 ·Seminars in Arthritis and Rheumatism ·Santiago Rodrigues-Manica, Alexandre Sepriano, Sofía Ramiro, Robert Landewé, Pascal Claudepierre, Anna Moltó, Maxime Dougados, M. van Lunteren, Désirée van der Heijde	2
8	The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis 2022 ·Lara D. Veeken ·(unknown), Murat Torğutalp, Valeria Ríos Rodríguez, Fabian Proft, Clementina López‐Medina, Maxime Dougados, Denis Poddubnyy	1
9	Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey 2021 ·The Journal of Rheumatology ·Anne Boel, Victoria Navarro‐Compán, Annelies Boonen, Philip J. Mease, Uta Kiltz, Maxime Dougados, Robert Landewé, Désirée van der Heijde	5
10	Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension 2021 ·Lara D. Veeken ·Désirée van der Heijde, Maxime Dougados, Walter P. Maksymowych, G. Bergman, Sean Curtis, Anjela Tzontcheva, Susan Huyck, George Philip, Joachim Sieper	3
11	Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department 2021 ·Rheumatology International ·(unknown), Maxime Dougados, Anna Moltó	11
12	Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study 2020 ·Annals of the Rheumatic Diseases ·Désirée van der Heijde, Lianne S. Gensler, Atul Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, (unknown), Dominique Baeten, (unknown), Jason Coarse, Marga Oortgiesen, Maxime Dougados	97
13	Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice 2020 ·Seminars in Arthritis and Rheumatism ·(unknown), Anna Moltó, Véred Abitbol, Loriane Gutermann, Ornella Conort, François Chast, Claire Goulvestre, Claire Le Jeunne, Stanislas Chaussade, Christian Roux, Frédéric Batteux, Maxime Dougados, Yannick Allanore, Jérôme Avouac	30
14	Self-reported competencies and educational needs of rheumatology nurses: Results of a national survey 2019 ·Joint Bone Spine ·Catherine Beauvais, Laure Gossec, Aurélien Mulliez, Françoise Fayet, (unknown), Sophie Pouplin, Serge Perrot, Christian Lamour, Laurence Carton, M Aubert, (unknown), Laurent Grange, (unknown), Maryse Mézières, Maxime Dougados, (unknown), Carine Savel	1
15	EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases 2019 ·RMD Open ·Aurélie Najm, Elena Nikiphorou, Marie Kostine, Christophe Richez, John D Pauling, Axel Finckh, Valentin Ritschl, Yeliz Prior, Petra Balážová, Simon Stones, Zoltán Szekanecz, Annamaria Iagnocco, Sofía Ramiro, Francisca Sivera, Maxime Dougados, Loreto Carmona, Gerd R Burmester, Dieter Wiek, Laure Gossec, Francis Bérenbaum	67
16	Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis 2018 ·Annals of the Rheumatic Diseases ·Maxime Dougados, Walter P. Maksymowych, Robert Landewé, Anna Moltó, Pascal Claudepierre, Manouk de Hooge, R. Lambert, R. Bonin, Jack F. Bukowski, Heather Jones, I. Logeart, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Désirée van der Heijde	33
17	Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study 2018 ·RMD Open ·Casper Webers, Sofía Ramiro, Robert Landewé, Désirée van der Heijde, Filip Van den Bosch, Maxime Dougados, Astrid van Tubergen, Annelies Boonen	15
18	Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial. 2017 ·PubMed ·(unknown), Y. Brault, Maxime Dougados, Laure Gossec	5
19	Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study breakdown → 2016 ·Annals of the Rheumatic Diseases ·Maxime Dougados, Désirée van der Heijde, Ying‐Chou Chen, Maria Greenwald, Edit Drescher, Jiajun Liu, Scott D. Beattie, Sarah Witt, Inmaculada de la Torre, C. Gaich, Terence Rooney, Douglas Schlichting, Stephanie de Bono, Paul Emery	301
20	Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study 2015 ·Annals of the Rheumatic Diseases ·Walter P. Maksymowych, Maxime Dougados, Désirée van der Heijde, Joachim Sieper, Jürgen Braun, Gustavo Citera, Filip Van den Bosch, I. Logeart, Joseph Wajdula, Heather Jones, Lisa Marshall, R. Bonin, Ron Pedersen, Bonnie Vlahos, Sameer Kotak, Jack F. Bukowski	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact